EUMCA News 

You can contact our Communications Director at Penny.Lukats@eumca.org or +44 7775 992 350

You can contact our

Communications Director at

Penny.Lukats@eumca.org or

+44 7775 992 350

Should medical cannabis be legalised?

Should medical cannabis be legalised?

Who would benefit from the legalisation of medical cannabis? Schubert says “chronic pain patients benefit from medical cannabis." “It could be the most disruptive change in the pharmaceutical industry for a long time. We would be able to switch patients from opiates...

EUMCA Member Tilray® Receives Complete GMP Certification At EU Campus

EUMCA Member Tilray® Receives Complete GMP Certification At EU Campus

Certification signals another milestone for EU campus as Tilray’s international medical cannabis hubLicensing expands company’s international export capacity to serve authorized medical cannabis markets Provides authorization to complete medical cannabis extraction...

The EUMCA: Pioneering access to medicinal cannabis

The EUMCA: Pioneering access to medicinal cannabis

"The latest data that came from a UK organisation, the CMC, involved analyzing 30 different products.. Only 38% of them had ingredients close to what was claimed on the label. In fact, one product had no cannabinoid in it at all." "To my mind, this whole area needs...

Get in touch

Please submit your membership enquiry and our team will be in touch to discuss

Or call +32 233 90 281

+32 233 90 281

info@eumca.org

EUMCA, Brussels, Belgium

Copyright ©2019 EUROPEAN MEDICINAL CANNABIS ASSOCIATION

Address: EUMCA, Immobilière du Noyer S.A.
Avenue Adolphe Lacomblé 69-71
B-1030 Bruxelles

Phone: +32 233 90 281

Linkedin: EUMCA

Twitter: @EUMCAOrg

Privacy policy: View here

Website by
Copyright ©2019 EUROPEAN MEDICINAL CANNABIS ASSOCIATION

Address: EUMCA, Immobilière du Noyer S.A.
Avenue Adolphe Lacomblé 69-71
B-1030 Bruxelles

Phone: +32 233 90 281

Linkedin: EUMCA

Twitter: @EUMCAOrg

Privacy policy: View here

Website by